Difference between revisions of "Team:TCU Taiwan/Project/Overview"
Line 8: | Line 8: | ||
background-size: 100% 100%; | background-size: 100% 100%; | ||
} | } | ||
− | #upto_table { | + | #upto_table { |
− | + | ||
position:static; | position:static; | ||
margin-left:10%; | margin-left:10%; | ||
− | margin-top: | + | margin-top:8%; |
width:80%; | width:80%; | ||
− | height: | + | height:50%; |
z-index:1; | z-index:1; | ||
overflow:visible; | overflow:visible; | ||
− | margin-bottom:- | + | margin-bottom:-5%; |
display: inline-block | display: inline-block | ||
− | |||
} | } | ||
#form { | #form { |
Revision as of 03:55, 29 July 2015
AMP. coli |
Antimicrobial peptides (AMPs), a peptide that have been proved to solve the rising problem of bacterial resistance. Our target is to develop it into a potential material of wound dressing.
|
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |